DISRUPTING DISEASE
Live / Registered — Registered (as of 15 Jul 2025)
What this means for you
Registered since 15 Jul 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98609018
- Registration number
- 7869579
- Mark type
- Stylized text
- Filed
- 19 Jun 2024
- Registered
- 15 Jul 2025
- Attorney of record
- Jennifer Kwon
Goods and services
- Class 042 — Scientific and technological services: Scientific research; scientific research in the fields of pharmaceuticals and medicine; chemical laboratories; medical research laboratories; providing scientific information in the field of biopharmaceuticals
Owner
- Alnylam Pharmaceuticals, Inc., Cambridge, MA, US
- Alnylam Pharmaceuticals, Inc., Cambridge, MA, US
Prosecution history
- 15 Jul 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 15 Jul 2025 — REGISTERED-SUPPLEMENTAL REGISTER
- 13 Jun 2025 — APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
- 14 May 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 14 May 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 14 May 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 21 Feb 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 21 Feb 2025 — NON-FINAL ACTION E-MAILED
- 21 Feb 2025 — NON-FINAL ACTION WRITTEN
- 25 Jan 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 25 Jan 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 25 Jan 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 29 Oct 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 29 Oct 2024 — NON-FINAL ACTION E-MAILED
- 29 Oct 2024 — NON-FINAL ACTION WRITTEN